Vadim Gurevich, CEO of GLW Medical Innovation (“GLW”), will represent his company at the Emerging Medtech Summit to discuss not only GLW’s latest R&D initiatives, but also their investment and strategic partnership needs. GLW is a medical device incubator focused on the design and development of cost-effective, high-margin implant and instrument solutions in various segments of the orthopedic market. They commercialize their products through exclusive distribution and education agreements with carefully selected sales organizations.
Mr. Gurevich has an extensive business career with over 19 years of leadership experience in medical technology. He has a documented record of success spanning a broad spectrum of disciplines, including orthopedic trauma, foot & ankle, urogynaecology, general surgery and neurosurgery with extensive M&A, licensing, and post-acquisition integration expertise. His career encompasses a series of executive and senior decision-making positions at Stryker Orthopaedics, Integra LifeSciences, Synovis Surgical (Baxter BioSurgery), and Gyrus Medical (Olympus).
Mr. Gurevich is also President & CEO of Novastep Inc., a US sales and distribution company focusing on products that treat conditions affecting the bones, joints, and soft tissues of the foot and ankle. He holds similar titles at Innov8ortho LLC, a sales distribution company specializing in musculoskeletal trauma injuries, specifically hip fracture care products.
Vadim Gurevich, CEO of GLW Medical Innovation (“GLW”), will represent his company at the Emerging Medtech Summit to discuss not only GLW’s latest R&D initiatives, but also their investment and strategic partnership needs. GLW is a medical device incubator focused on the design and development of cost-effective, high-margin implant and instrument solutions in various segments of the orthopedic market. They commercialize their products through exclusive distribution and education agreements with carefully selected sales organizations.
Mr. Gurevich has an extensive business career with over 19 years of leadership experience in medical technology. He has a documented record of success spanning a broad spectrum of disciplines, including orthopedic trauma, foot & ankle, urogynaecology, general surgery and neurosurgery with extensive M&A, licensing, and post-acquisition integration expertise. His career encompasses a series of executive and senior decision-making positions at Stryker Orthopaedics, Integra LifeSciences, Synovis Surgical (Baxter BioSurgery), and Gyrus Medical (Olympus).
Mr. Gurevich is also President & CEO of Novastep Inc., a US sales and distribution company focusing on products that treat conditions affecting the bones, joints, and soft tissues of the foot and ankle. He holds similar titles at Innov8ortho LLC, a sales distribution company specializing in musculoskeletal trauma injuries, specifically hip fracture care products.
17011 Beach Blvd, Suite 500 Huntington Beach, CA 92647
714-847-3540© 2025 Life Science Intelligence, Inc., All Rights Reserved. | Privacy Policy